chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt came to health room 2 hours p/vacc, c/o pins and needles in r/hand and finger tips hurting.  Pt was unable to hold pencil and feel cotton touch on hands. Mom took her to MD was out of school 3 days. Increased pain as parathesis subsided.
Patient given a Janssen COVID vaccine and she did not meet the age criteria for the vaccine, she is only 17 and Janssen is licensed for 18 years and older.
Sneezed 10 times in the parking lot upon leaving, then hands turned red.  When she went to the store with her husband right after that, her tongue started feeling dry and getting hard with itching.  She started to feel light headed and her husband told her she was "red all over."  She came back to the vaccination area at 1420 and was escorted up to the Emergency Department.  At 1600, she had received Epinephrine, Solumedrol and Pepcid and was feeling much better--her tongue was feeling back to normal and just feeling jittery from epi.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 02-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Redness several inches under the vaccine administration sight, deep, throbbing, tingling  ache/pain down the arm and into the fingers that (patient said it feels similar to a sprain),
Patient became ill with bad headache within hours of shot. Feet, lower legs and hands became very swollen by the next day. So bad she could not walk. Could not even touch her feet. Hands had very limited use. She ended up being hospitalized twice and is now in a rehab facility.
Following administration of vax, that evening, pt had inc temp 105 R & unconsolable crying x 1.5hrs; inc temp lasted through the evening;
Patient stated receiving the Janssen vaccine for hist first booster dose at an immunization clinic. Patient stated that the injector "put the needle in really hard." Patient reports shoulder pain since the time of that injection which he currently describes as dull pain with some movements but that does not impact his ability to use his arm or perform daily tasks. Patient stated that the pain did improve with time, but also gets worse at times. Patient also remembered feeling generally sick after the dose of Janssen, about an hour and a half after the administration, but that those symptoms resolved with time. Patient received second booster dose of covid vaccine yesterday in R arm with no complaints.
Pt complaining left upper arm painful around injection site no redness, swelling or fever noted. Take OTC TYLENOL. Apply ice or heat.
WIthin 3 hours of dose administration, observed and felt non-painful muscle "twitching" in both legs. Both hands and feet became cold with pallor and Raynaud's phenomenon observed in both hands feet requiring constant rewarming. Approximately 8 hours later, experienced  bilateral hand and foot "pins and needles" sensations.  Sought medical treatment today 7/12 as symptoms intermittently persist in addition to lightheadedness (feeling as though fainting would occur) and brain fog experienced for 6 hours on  7/3.  On 7/10, was awakened from sleep with tachycardia (peak HR 148 lasting 49 minutes as captured by Fitbit wearable device). The following am 7/11, numb sensation felt on L arm with continued "pins and needles " sensations experienced in Bilateral hands and feet. This writer was unable to work that day as a result.
Hives and fever presented 6 days following the vaccine. Hives started on trunk and spread to arms, legs, face and feet throughout the day/night. Low grade fever was treated with cool cloth (no medication. Hives were treated by pediatrician with 2.25 ml hydroxyzine, ever six hours as needed. Medication was used as needed for four days, until rash/hives had cleared.
1-hour post vaccination, heart rate increased to an unknown rate, feelings of throat closing, feeling of pounding in chest and headache, after 24 hours pt got rash that has lasted 2 weeks and is still present
Initial report was received on 23 November 2011 from a consumer who is also the patient. A 71 year-old female patient had received on 31 October 2011 an intramuscular right deltoid injection of FLUZONE HIGH-DOSE, lot number UH436AC and the next day on 01 November 2011, experienced vertigo, vomiting, swelling under one eye where a white sac developed, facial swelling on the right side and crusting of both eyes. The patient went to the ER (emergency room) and was treated and released (treatments not reported). The patient was to follow-up with PCP (primary care physician). According to the patient, the symptoms "continued for one week" but she also reported that the symptoms have diminished but had not completely recovered. No further information was available at the time of report. The patient's outcome was not recovered. Documents held by sender: none.
Got a bruise the size of a baseball at the site the next day - & also felt flu like sx. Then, 2 days later arm got red, hot, swollen & painful.
cardiac arrhythmia; dizziness/lightheadedness; nausea; muscle weakness; extreme fatigue; lost consciousness/She is in and out of consciousness; extreme weakness; extremely low blood pressure; tachycardia when resting/heart rate is high/HR gets up to 135; One foot and leg became very cold and turned blue; One foot and leg became very cold and turned blue; other foot warm and hot; This is a spontaneous report from a contactable consumer (patient's sister). A 30-year-old non-pregnant female patient received the second dose of bnt162b2 (BNT162B2 reported as PFIZER COVID 19 VACCINE; lot number: EN/ EW 6198; expiration date: unknown), at vaccination age of 30-year-old via an unspecified route of administration in the left arm on 02Mar2021 as a single dose for covid-19 immunisation. The patient medical history was not reported. The patient was not diagnosed with covid prior to vaccination. The patient received the first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID 19 VACCINE; lot number: EN6198), at vaccination age of 30-year-old via an unspecified route of administration in the left arm on 09Feb2021 as a single dose for covid-19 immunisation but had weakness, fainted, lost consciousness and concussion. There were no concomitant medications. The patient did not receive other vaccine in four weeks. The reporter mentioned that on the next day after vaccination (03Mar2021), the patient's one foot and leg became very cold and turned blue other foot warm and hot started cardiac arrhythmia, dizziness, lightheadedness, nausea, muscle weakness, extreme fatigue, extremely low blood pressure and tachycardia when resting. The reporter stated that since 02Mar2021, she hasn't been able to get out of bed due to extreme weakness. The reporter also mentioned that her heart rate (HR) gets up to 135 [unit unspecified]. The reporter also stated that the patient was wearing a heart monitor and was waiting for data. They went to the emergency room (ER) on 12Mar2021 due to concerns of blood clot, ruled out blood clot. The doctors can't explain what is happening to her. She was extremely healthy and fit, no previous cardiac or energy issues. No blood pressure issues or family HX. She says she "feels like she's dying". The adverse events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, and life-threatening illness (immediate risk of death from the event). The hospitalization was reported as 1 day. It was unknown if the events received treatment. The patient was not tested post vaccination. It was further reported that her sister had the second Covid shot 02Mar2021 and a few hours later she lost consciousness. She has been in the hospital ever since. She was in and out of consciousness, her blood pressure is low, and her heart rate is high. One of her legs is blue and cold, the other is hot. She cannot get out of the bed. The doctors don't know what is wrong. It was mentioned that the patient was healthy and not taking any medication. The outcome of the events was not recovered.
PATIENT HAD SWELLING/BLISTERING AND INFECTED LOOKING SKIN AROUND AREA OF ADMINISTRATION. NO PUSS OR SEEPING WAS OBSERVED AT TIME THE PATIENT PRESENTED, HOWEVER, THE PATIENT DID STATE THAT HE HAD OBSERVED SOME PUSS AND SEEPING IN THE PREVIOUS DAYS. UPON EXAMINATION, I RECOMMENDED THAT THE PATIENT SEE HIS PRIMARY CARE DOCTOR, AS THIS DID LOOK LIKE AN INFECTION, BUT BASED ON THE PRESENTATION DATE, WAS NOT UNDER THE IMPRESSION THAT THE ADVERSE EVENT WOULD BE RELATED TO THE IMMUNIZATION.
Patient received a second dose today, the first dose was Pfizer while the second was Moderna. Advised that a VAERS form would be submitted. Counseled about immunity benefits and concerns with mixing doses. Patient verbalized understanding.
the patient received an improperly stored dose of Proquad; This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided.  On 02-SEP-2020, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) albumin status: rHA, lot # T003835, expiration date: 01-AUG-2021 (dose and route of administration were not reported) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (STERILE DILUENT).  It was reported that the dose of the product administered to the patient was not stored properly for the time frame of 7 hours in the temperature 0 degrees Celsius. There was no previous temperature excursion. Digital Data Logger was not involved.  The outcome of medication error was unknown.
chills & fever w/onset of swelling, pain @ inject site; started to take ASA; 18JUN chills & fever cont; Sat & sun felt better; sl lump @ inject site; 21JUN, no fever but swelling of lt deltoid area; On exam, swelling & heat over lt deltoid
Did not provide them  a second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Did not provide them  a second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Did not provide them  a second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Did not provide them  a second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and Treatment medications were not provided by reporter.
Red warm rash w raised hives mainly over left side of abdomen but extending to right side as well. Very itchy
pt began vomiting 8hr p/vax;parent also noted child skin to feel cold & clammy but sweaty;child then had dry retching x 2hr;;p/that 2hr child was somnolent for 20min & diff to arouse;parent woke child up & was able to feed child;
I developed pain and soreness in my left side breast where I imagine the lymph nodes to be. It felt very tender and inflamed for a few days. I was getting quite worried about to go see my doctor and then I heard that this can happen post vaccine in the side of the shot. I still have some tenderness but it has improved.  It was quite painful the type that?s hard to ignore.
SORE ARM; FEVER; HEADACHES; NAUSEA; This spontaneous report received from a consumer via a company representative concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced sore arm, fever, headaches, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm, fever, headaches, and nausea. This report was non-serious. This case, from the same reporter is linked to 20210837630.
DIAPHORETIC, HYPOTENSIVE 95/45, BRADYCARDIC 45, PRESYNCOPE LAYED ON STRETCHER, DRANK WATER, SYMPTOMS RESOLVED. OPTED TO GO HOME ONCE SYMPTOMS RESOLVED
Enlarged left axillary lymph nodes developed 6 days after first vaccine. Then approximately 10-15 min after 2nd injection, upper arms became numb and tingly. Became dizzy. Sweating. Upper thighs tingling. Thready pulse. Alerted staff. Pulse ox checked normal. Symptoms improved after 30 minutes. Very tender and enlarged left axillary lymph nodes followed, have not resolved.
I had headache, cough, chest congestion, chills, fever, weakness, and fatigue. I contacted the doctor and was given Paxlovid which did help. I was sick for about three weeks.
Information has been received from a physician concerning a female who in 1995 was vaccinated with varicella virus vaccine live. Subsequently, the patient experienced a lack of response. No further information is available.
Patient developed near immediate flushing, itching, and discomfort in her face and neck. Her heart rate sped up (>120) and her blood pressure was elevated (>140). Her oxygen saturation level was normal. She was observed at the vaccination waiting area for 30 minutes, but ultimately moved to the urgent care for additional monitoring and management. After 15 minutes there she was given a dose of epinephrine. She reported relief from her clinical symptoms including abatement of the  flushing, itching, and anxiety. She will take Benadryl at home and consider her Epipen if needed. She will follow-up with me on the increased blood pressure and heart rate
Extreme left facial pain, similar to trigeminal neuralgia. Continued from January through March 2021. Required medication management with frequent changes.
Admitted 12/9/2022  with acute hypoxic respiratory failure 2/ 2 CF exacerbation 2/2 COVID-19 with concern for superimposed bacterial pneumonia. Patient with increased work of breathing and tachypnea but good aeration throughout lung fields. Saturating >90% on 20 lpm HFNC at 0.6 FiO2. Will plan to wean HFNC settings as tolerated and continue patient's home "sick" respiratory plan. Given COVID-19 infection with hx of CF, will start Remdesivir and Decadron. Will also continue ceftazidime and tobramycin due to concern for superimposed bacterial pneumonia.
Covid on; allergic reaction; itching at injection site; burning at injection site; swelling at injection site; tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid on), HYPERSENSITIVITY (allergic reaction), VACCINATION SITE PRURITUS (itching at injection site), VACCINATION SITE PAIN (burning at injection site) and VACCINATION SITE SWELLING (swelling at injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CLONIDINE, ALISKIREN, LEVOTHYROXINE SODIUM (SYNTHROID) and LIFITEGRAST (XIIDRA) for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced VACCINATION SITE REACTION (Covid on), HYPERSENSITIVITY (allergic reaction), VACCINATION SITE PRURITUS (itching at injection site), VACCINATION SITE PAIN (burning at injection site), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE PAIN (tenderness at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE REACTION (Covid on), HYPERSENSITIVITY (allergic reaction), VACCINATION SITE PRURITUS (itching at injection site), VACCINATION SITE PAIN (burning at injection site), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE PAIN (tenderness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took Benadryl oral Benadryl topical. Other relevant medication history included OTC supplements.
I started out with just typical soreness in my arm, later that night I got a headache and fatigue. Monday I woke up with the same headache which grew into a migraine. Late Monday morning the left side of my neck was sore along with the left arm around the injection site, and I experienced numbness in my left cheek. The numbness in my cheek went away by this morning for the most part and now all that?s left is the migraine and some sinus pressure.
severe flushing (extreme heat and tingling started in toes and moved up body); tachycardia; itching/scratchy throat not relieved by drinking water); dizziness; feeling of impending doom
COVID arm. 9 days post vaccine. Bruise at top of swelling site, week post first symptom. No other issues.
Large edematous area 44x38 mm. on left lower thigh.  No redness, pain to touch or palpation. No evidence of infection.  First seen by this nurse on 3-16-2011 the area was measured at that date.
Headache, Arthralgia, NauseaVomiting, numbness in throat area, face felt swollen but no evidence of swelling  Narrative:
patient had the first dose moderna vaccine. Came to the pharmacy and pharmacist gave patient pfizer covid 19 vaccine.
It started with a scratchy throat and just feeling tired on Thursday night 10/13/22. During the night, I thought I was sleeping wrong because I was hurting everywhere. I tried to change positions, and when I got up the next morning, all of my joints were aching. I was very congested. I took a COVID-19 test and got a positive result. It was headaches, body aches, no fever, sore throat, congestion, and feeling very congested and tired. A month and a half before, I had been exposed to someone with COVID-19, and my doctor prescribed PAXLOVID prior in case I did ever test positive for COVID-19. In this case, I did not need to contact my doctor because I already had the prescription and started PAXLOVID on 10/14/2022. After PAXLOVID, I finished that on Tuesday, 10/18/22. I tested negative on 10/21/22, but by that evening, I started to feel sick again. It was the same symptoms, but not as much with the body aches. It was a rebound case. I did do a virtual visit with my doctor on 10/25/22 because I was still feeling bad. He said I needed to treat the symptoms and let it run its course. My GI doctor noted not to take the HUMIRA until I was well again because of my immune system. I tested negative on Saturday 10/29/22, and I started feeling somewhat better. The next week after that, I felt a little bit dizzy and very fatigued. I would get up in the morning and feel good, then by the afternoon I felt very tired. I kept feeling worse and worse. By Sunday, 11/6/22, I was feeling dizzy with pressure in my face and head. I went to see my doctor in person on 11/9/22. I saw him and he started treating me for a sinus infection and he said it looked like I was very infected and had fluid in my ears. So he noted it was vertigo and a sinus infection and put me on CIPRO which I'm still on. I'm also taking MUCINEX and DRAMAMINE and FLONASE. I'm still having the pressure in my face and head, and I'm still experiencing vertigo. Not as much as pain, but I am thinking I'll have to go back to my doctor. Still experiencing the sinus infection, congestion, dizziness and fatigue even though I'm no longer testing positive.
Practically immediate sensation of the liquid coming to my soft palate, change in sensitivity, change of taste in the mouse. It was quite mild and almost gone within 15 min, so I did not file a complain and no treatment was used. These are the only unusual symptoms that I had. Other symptoms develop few hours after injection and included sore arm, mild body muscle pain and joint pain (mostly small joints of hands). These symptoms last 2 days. The tiredness persisted for about a week after the vaccination.
onset of severe L back pain, L arm pain and L chest pain very similar to previously experienced brachial plexopathy
Initial information has been received from a 74 year old female consumer with an allergy to corns and sulfonamide who on 22-APR-2008 was vaccinated with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot# not provided). There was no concomitant medication. On 22-APR-2008 the patient experienced redness, swelling, fever up to 102d, muscle aches and rash. Follow up information received from the physician indicated that the patient called the physician and reported that she had a localized reaction to her arm which included redness, swelling and pain. The patient never mentioned to him that she had fever. At the time of reporting the patient had not recovered. Additional information is not expected.
Chills, body pain, headache, sweats, earaches, sore throat, neck pressure, fatigue, dizziness
Ten days post vax, the pt developed a fine rash all over his body from measles virus vax live, mumps virus vax live, and rubella virus vax live. No other symptoms were reported. The pt sought unspecified medical attention and recovered.   Additional information has been requested.
administered  only the liquid component of the Menveo; administered  only the liquid component of the Menveo; This case was reported by a physician via call center representative and described the occurrence of inappropriate preparation of medication in a 11-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA521A, expiry date 30th April 2022) for prophylaxis.   On 30th July 2021, the patient received Menveo. On 30th July 2021, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The patient was inadvertently administered only the liquid component of the Menveo resulting in the administration of liquid component of MenACWY without lyopholized A component of the vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. At the time of the report the patient had not reported any issues.  The reporter consented to follow up.